Human Genome Research federal obligations in FY2024

How Human Genome Research meets FY2024 on USAspending

$2,881,096,663.38 is the obligation sum on the intersection of CFDA 93.172 and fiscal year 2024. The FY cell is 90.4% of the program-wide $3,188,700,434.55 book in this extract. It is not every federal dollar tagged to FY2024, not the listing’s all-year $3,188,700,434.55 book restated as one year, and not an outlay. FEC donations do not fund these USAspending obligations. This packet lists no award recipients.

CFDA 93.172 (/programs/93.172/) drops the year filter. FY2024 federal spending (/fiscal-years/2024/) drops the CFDA filter. All programs (/programs/) and All spending ties (/ties/) are parent indexes. Only this page applies both filters at once. A later ingest can restate $2,881,096,663.38 without changing the join keys.

What CFDA 93.172 contributes to the pair

Official catalog string: HUMAN GENOME RESEARCH. Display name: Human Genome Research. Program-wide obligations in this extract are $3,188,700,434.55 across 1,118 awards. Those parent figures are not the FY2024 headline. Mixing the listing with other genome or genetics catalog lines that are not CFDA 93.172 would invent a combined book. Human Genome Research is CFDA 93.172. FY2024 is one yearlyTrend bucket, not a claim that 893 genomes were sequenced. Investigator names, campus names, and dataset identifiers are unpublished. Do not merge this listing with a different genetics CFDA.

What fiscal year 2024 contributes to the pair

FY2024 is a USAspending fiscal-year key, not a calendar year and not a finished cash year. FY figures can be incomplete. Awards that carry a different year sit outside this cell even if the listing is still Human Genome Research. Do not annualize $2,881,096,663.38 into a run-rate the packet never computed.

893 FY2024 award records are not 893 finished studies or 893 unique laboratories

893 is the year-cell award-record count, not 893 finished studies or 893 unique laboratories. About $3,226,312.05 per year-cell record is arithmetic on $2,881,096,663.38 and 893, not a typical payment. The parent’s 1,118 awards belong on CFDA 93.172 without the year filter. Unique recipients remain unpublished.

Caveats on Human Genome Research obligations in FY2024

An obligation is a commitment. An outlay is a Treasury payment. $2,881,096,663.38 is the commitment figure. The join cannot support a named-lab roster, a principal-investigator directory, or a dataset catalog. Keep the obligation label. If a chart mixes other genome or genetics catalog lines that are not CFDA 93.172 with CFDA 93.172 in FY2024, the chart has left this join.

Hubs: /programs/93.172/ (CFDA 93.172), /fiscal-years/2024/ (FY2024 federal spending), /programs/ (All programs), /ties/ (All spending ties). None convert this cell into a recipient list. Cite Human Genome Research, FY2024, CFDA 93.172, $2,881,096,663.38, 893 awards, USAspending.gov, obligations only. Keep Human Genome Research and FY2024 on the same line as $2,881,096,663.38. CFDA 93.172 remains the program key; fiscal year 2024 remains the time key. Obligations of $2,881,096,663.38 are not outlays and not a named-lab roster, a principal-investigator directory, or a dataset catalog. Original filings remain on USAspending.gov for this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this program-year join. All programs and All spending ties are larger indexes than this cell. A later USAspending ingest can restate $2,881,096,663.38 without changing CFDA 93.172 or FY2024. Do not invent contractors or award recipients for Human Genome Research. The 893 year-cell awards are still not 893 finished studies or 893 unique laboratories. Keep Human Genome Research and FY2024 on the same line as $2,881,096,663.38. CFDA 93.172 remains the program key; fiscal year 2024 remains the time key. Obligations of $2,881,096,663.38 are not outlays and not a named-lab roster, a principal-investigator directory, or a dataset catalog. Original filings remain on USAspending.gov for this yearlyTrend cell.

Questions

How much Human Genome Research spending is in FY2024?

USAspending.gov records $2,881,096,663.38 in Human Genome Research obligations for FY2024 (CFDA 93.172). That is a program × year join, not an outlay and not the government-wide FY2024 total. Original filings remain on USAspending.gov.

Do 893 awards mean 893 genome projects finished in FY2024?

No. 893 is the year-cell award-record count, not 893 finished studies or 893 unique laboratories. A mean of about $3,226,312.05 is arithmetic on packet facts, not a typical payment. Unique recipients are unpublished. Original filings remain on USAspending.gov.

Is $2,881,096,663.38 cash already paid for Human Genome Research in FY2024?

No. $2,881,096,663.38 is an obligation aggregate for Human Genome Research in FY2024. Outlays, remaining balances, and cash already paid are unpublished on this packet. Keep the obligation label. USAspending.gov remains the source. Keep Human Genome Research and FY2024 together when citing $2,881,096,663.38.

Which pages parent Human Genome Research FY2024?

CFDA 93.172 is the program parent. FY2024 federal spending is the year parent. All programs lists other CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Human Genome Research × FY2024 at $2,881,096,663.38.